纸尿裤中含甲酰胺？Babycare：已按欧标送检，未检出

The core of this incident is that multiple well-known diaper brands have been found to contain formamide, a toxic substance. Below are key key points readers need to know:

1. Incident background: Economic Information Daily commissioned a professional institution to test infant diaper products from several brands on the Chinese market. Formamide was detected in products from brands including Huggies, Beaba and Babycare. Formamide is a reproductive toxicant that is explicitly banned for use in cosmetics in China.

2. Babycare’s response and current status: China’s current national standards do not specify a limit for formamide in diapers. Babycare proactively conducted testing in accordance with the high-concern substance requirements of the EU REACH Regulation, and the result showed no formamide detected. All of the brand’s currently sold diapers meet all relevant Chinese standards, and it has not received any non-compliance notification from regulatory authorities.

3. Follow-up developments: Babycare has contacted the media to obtain sample information for further verification, and has also commissioned multiple authoritative third-party institutions to conduct independent sampling tests on its full range of diapers, with the entire process notarized. The test results will be open to public supervision.

This formamide-related public opinion incident in the diaper industry provides multiple key takeaways for maternal and infant brand practitioners, as outlined below:

1. Changes on the consumer side: Consumers today are extremely sensitive to the safety of maternal and infant products. Even potential risks from substances not yet covered by national standards can trigger widespread public concern, and safety has become the core competitiveness for maternal and infant brands.

2. Implication for standards: There is currently no unified national standard in China for formamide testing methods or limit requirements for diapers. Brands cannot stop at just meeting existing national standards; they need to proactively monitor potential safety risks and conduct advance inspection and control.

3. Reference for public relations response: When facing similar public opinion incidents, brands should issue a response immediately, proactively demonstrate their compliance, share test results aligned with higher international standards (beyond national requirements) to earn trust, and reduce negative impact through proactive full-range sampling testing with notarization and opening results to public supervision.

This formamide incident brings risk alerts and response references for maternal and infant category sellers, with key takeaways as follows:

1. Product selection risk alert: There is currently no unified testing requirement, standardized method or limit for formamide in China’s diaper category, leaving a regulatory gap that makes it prone to sudden public opinion crises. When selecting products, sellers cannot only check whether products meet national standards, but should also pay attention to whether brands have implemented control over such potential risky substances.

2. Reference for public opinion response: Babycare’s response framework is worth learning: issue an immediate public response, clarify compliance, proactively use higher international standards to prove product safety, conduct full-range sampling testing with notarization, and open the process to public supervision. This approach can quickly ease consumer concerns and reduce negative impact.

3. Market opportunity: As consumers demand increasingly higher safety standards for maternal and infant products, sellers can prioritize products that meet higher safety standards such as the EU’s, which helps earn consumer trust and capture greater market share.

This diaper formamide incident offers many insights for diaper manufacturers, with key takeaways as follows:

1. Changing demand on the production side: Although China has not yet established a unified control standard for formamide in diapers, downstream brands and end consumers already attach high importance to this toxic substance. Manufacturers cannot stop at meeting existing national standards; they need to proactively control formamide and other potentially risky substances to upgrade production safety standards.

2. Commercial competitive opportunity: If manufacturers can optimize production processes in advance to control risky substances and bring products up to higher international safety standards such as the EU’s, they can build production advantages, win more orders from top-tier maternal and infant brands with high quality requirements, and improve their overall competitiveness.

3. Development insight: Manufacturers need to proactively adapt to changing consumer demand, track new consumer requirements for product safety, and upgrade production control systems in advance to keep up with industry development and avoid being eliminated from the market.

This diaper formamide incident exposes key pain points in the maternal and infant industry and also brings new business opportunities for relevant service providers, with key takeaways as follows:

1. Current industry pain points for clients: For confirmed toxic substances like formamide in diapers, China lacks unified testing methods and limit requirements. Brands face both compliance and public opinion risks, and there is urgent demand for professional third-party testing services to help brands prove product safety. Consumers also have strong demand for authoritative, impartial testing results.

2. Industry development trend: A growing number of leading maternal and infant brands are no longer satisfied with only meeting national standards, and have started to proactively adopt higher international safety standards such as the EU’s. Demand for testing risky substances not covered by national standards is growing, and brands also need open, notarized testing processes to earn consumer trust.

3. Business expansion direction: Third-party testing and other relevant service providers can develop targeted testing services for risky substances like formamide that are not regulated by national standards, meet brands’ demand for full-range self-inspection and open sampling testing, and add supporting notarization services to unlock new business growth.

This diaper formamide public opinion incident offers much valuable reference for operation management and risk prevention for maternal and infant product platforms, with key takeaways as follows:

1. Risk alert: The standard gap for formamide in the diaper category makes the sector prone to large-scale public opinion incidents that can damage the platform’s overall reputation. Platforms need to implement advance risk prevention and control, and must not take the issue lightly.

2. Operation management suggestion: Platforms can improve quality requirements for enrolled brands, encourage brands to build independent safety testing mechanisms, and require brands to publish test results for high-concern risky substances (especially those not covered by national standards) to ease consumer concerns in advance.

3. Sourcing and risk mitigation: When recruiting new brands, platforms can prioritize maternal and infant brands that proactively adopt higher international safety standards and build complete self-inspection systems, which aligns with consumers’ core current demand for safety. When similar public opinion incidents occur, platforms can guide brands to disclose information and respond to questions in a timely manner to reduce negative impact on the platform.

This diaper formamide incident exposes new problems in China’s maternal and infant product industry and points to new directions for industrial research, with key takeaways as follows:

1. Exposed new problems: The update of China’s safety standards for maternal and infant products lags behind industrial development and consumer demand. For formamide, a substance clearly identified as reproductive toxic, China has not yet introduced unified testing methods or limit requirements, creating a clear regulatory gap that can easily trigger an industry-wide trust crisis.

2. New industrial trend: Leading maternal and infant brands in China have already started to proactively align with higher international standards and control risky substances in accordance with EU REACH Regulation requirements. This shows that high consumer demand for safety is already forcing industry standard upgrades, and the entire industry is moving toward higher quality development.

3. Implications for policy and research: This incident reminds researchers to pay attention to the problem of outdated standards in domestic niche product categories, and also offers insights for policy making. Relevant authorities need to accelerate the improvement of the safety standard system for maternal and infant products, incorporate the latest risk research findings, fill regulatory gaps, standardize industry development, and protect consumer rights.